Image

D-RSBI Versus RSBI for Predicting Weaning Success in COPD Patients

D-RSBI Versus RSBI for Predicting Weaning Success in COPD Patients

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This prospective observational cohort study aims to compare the predictive accuracy of diaphragmatic rapid shallow breathing index (D-RSBI) versus traditional rapid shallow breathing index (RSBI) for predicting weaning success from invasive mechanical ventilation in COPD patients. Diaphragmatic ultrasound measurements will be performed during spontaneous breathing trials, and patients will be followed for 72 hours after extubation to assess weaning outcomes.

Eligibility

Inclusion Criteria:

  • Mechanically ventilated COPD patients fulfilling standard weaning readiness criteria.
  • Invasive mechanical ventilation for more than 24 hours before spontaneous breathing trial.
  • Hemodynamically stable without significant vasopressor support.
  • Adequate oxygenation with FiO2 ≤ 0.5 and PEEP ≤ 8 cmH2O .
  • Preserved mental status and ability to initiate spontaneous breathing.
  • Successful tolerance of spontaneous breathing trial conducted on CPAP mode with pressure support ≤ 8 cmH2O.

Exclusion Criteria:

  • Refusal of consent
  • Neuromuscular disease, phrenic nerve palsy, or diaphragmatic paralysis.
  • Large pneumothorax or pathology interfering with ultrasound assessment.
  • Terminal extubation.
  • Recent major thoracic surgery.
  • Poor sonographic window despite repeated attempts.

Study details
    Chronic Obstructive Pulmonary Disease (COPD)
    Mechanical Ventilator Weaning

NCT07590362

Sohag University

27 June 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.